The phenotypic characterization of normal and neoplastic cells and their isolation for functional and molecular analysis by flow cytometry is fundamental to cancer research. The Flow Cytometry Shared Resource assists HICCC members in flow cytometry-based studies. The capacity of the facility has increased substantially over the past five years due to the acquisition of new instruments and the hiring of additional personnel. The facility now operates six instruments, including three fluorescence-activated cell sorters and two advanced cell analyzers. The cell sorters allow high-speed cell sorting and can detect up to 12 fiuorescent parameters. One sorter in addition is equipped with a laser that enables detection of the living color fluorescent proteins dsRed and the dsRed derivatives mCherry and tdTomato;one instrument Is placed in a biosafety hood to enable sorting of primary human material. The two advanced cell analyzers besides multi-color fluorescence are able to perform various specialty applications such as multiple fluorescent protein analysis including dsRed derivatives, calcium flux measurements, determination of DNA content in live cells, and identification of the """"""""side population"""""""". In addition to those sophisticated instruments, the facility provides access to a user-operated basic cytometer permitting four-color immunophenotyping as well as cell cycle and apoptosis assays. The three analyzers are accessible for investigators around-the-clock. The facility manager since 2004 is Ms. Kristie Gordon, who has more than 25-years of experience in operating flow cytometers. The facility director since 2007 is Dr. Ulf Klein, whose past and present research on B-cell malignancies involves the use of various flow cytometrical approaches. Over the last several years, the services of the facility have benefited more than 100 Columbia University Pis, with HICCC members comprising the main clients, accounting for more than 60% of usage. This high usage allows the facility to offer the services at low fees, which are further reduced for HICCC members. The sophisticated equipment available in the facility allows investigators at Columbia to perform the highest state-of-the-art research in the area of fiow cytometry, and therefore represent a vital resource for HICCC members.

Public Health Relevance

The ability to characterize and isolate defined cell populations for functional and molecular analysis by fiow c^ometry has become an essential tool in cancer research. The Flow Cytometry Shared Resource provides state-of-the-art instruments and has long-standing expertise in flow-sorting and analysis, thus supporting the research of Cancer Center members. This intensively used facility is a crucial part ofthe HICCC.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA013696-40
Application #
8753118
Study Section
Subcommittee G - Education (NCI)
Project Start
1997-07-04
Project End
2019-06-30
Budget Start
2014-07-17
Budget End
2015-06-30
Support Year
40
Fiscal Year
2014
Total Cost
$146,107
Indirect Cost
$54,790
Name
Columbia University (N.Y.)
Department
Type
DUNS #
621889815
City
New York
State
NY
Country
United States
Zip Code
10032
Villasante, A; Sakaguchi, K; Kim, J et al. (2017) Vascularized Tissue-Engineered Model for Studying Drug Resistance in Neuroblastoma. Theranostics 7:4099-4117
Ma, Kevin K; Lin, James; Boudreault, Katherine et al. (2017) PHENOTYPING CHOROIDEREMIA AND ITS CARRIER STATE WITH MULTIMODAL IMAGING TECHNIQUES. Retin Cases Brief Rep 11 Suppl 1:S178-S181
Kampers, Johanna; Orjuela-Grimm, Manuela; Schober, Tilmann et al. (2017) Classical Hodgkin lymphoma-type PTLD after solid organ transplantation in children: a report on 17 patients treated according to subsequent GPOH-HD treatment schedules. Leuk Lymphoma 58:633-638
Cabral, Thiago; DiCarlo, James E; Justus, Sally et al. (2017) CRISPR applications in ophthalmologic genome surgery. Curr Opin Ophthalmol 28:252-259
Velez, Gabriel; Bassuk, Alexander G; Colgan, Diana et al. (2017) Therapeutic drug repositioning using personalized proteomics of liquid biopsies. JCI Insight 2:
Dutta, Aditya; Panja, Sukanya; Virk, Renu K et al. (2017) Co-clinical Analysis of a Genetically Engineered Mouse Model and Human Prostate Cancer Reveals Significance of NKX3.1 Expression for Response to 5?-reductase Inhibition. Eur Urol 72:499-506
Chiang, Wei-Chieh; Chan, Priscilla; Wissinger, Bernd et al. (2017) Achromatopsia mutations target sequential steps of ATF6 activation. Proc Natl Acad Sci U S A 114:400-405
Marks, Lianna J; Oberg, Jennifer A; Pendrick, Danielle et al. (2017) Precision Medicine in Children and Young Adults with Hematologic Malignancies and Blood Disorders: The Columbia University Experience. Front Pediatr 5:265
Kanner, Scott A; Morgenstern, Travis; Colecraft, Henry M (2017) Sculpting ion channel functional expression with engineered ubiquitin ligases. Elife 6:
Wang, Tian; Tsang, Stephen H; Chen, Jeannie (2017) Two pathways of rod photoreceptor cell death induced by elevated cGMP. Hum Mol Genet 26:2299-2306

Showing the most recent 10 out of 263 publications